Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-17 · accession 0001628280-25-013546 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-18 | 2025-03-17 | CPIX | Krogulski Kenneth | Dir | A - Grant | $5.17 | +5,000 | 278.8K | +2% | +$25.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-17 | A | A | 4,000 | $5.17 | 282,843 | D | — | — | (F1) Restricted stock award will vest 100% on March 17, 2026. |
| 2 | Common | Common Stock | 2025-03-17 | A | A | 1,000 | $5.17 | 278,843 | D | — | — | (F1) Restricted stock award will vest 100% on March 17, 2026. |